{
    "nctId": "NCT04414033",
    "briefTitle": "Bubble: A New VR-AI Way of Treatment for Hot Flashes in Women With Breast Cancer",
    "officialTitle": "Bubble: A New VR-AI Way of Treatment for Hot Flashes in Women With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Hot Flashes, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 37,
    "primaryOutcomeMeasure": "Demographic and background (disease & treatment-elated) information",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Females between the ages of 18 and 60\n* Having an existing diagnosis of breast or ovarian cancer\n* Receiving standard-of-care chemotherapy, endocrine therapy or estrogen blocking anti-cancer treatment\n* The woman reported experiencing hot flashes at least once per day for a duration of at least 7 days prior to the beginning of the study and hot flashes for at least 30 days prior to the beginning of the study\n* No chronic migraine headaches, seizure disorders, serious vestibular disorders, or pathological vertigo\n* No serious psychiatric disorders\n* Not pregnant\n* No current substance abuse\n* Not participating in other forms of therapy\n* Not using medical marijuana.\n\nExclusion Criteria:\n\n\\* women aged 28-55 with breast cancer suffering from hot flashes",
    "sex": "FEMALE",
    "minimumAge": "28 Years",
    "stdAges": "ADULT"
}